Table of Contents
Chapter 1. Global Lyme Disease Treatment Market Executive Summary
1.1. Global Lyme Disease Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Administration Route
1.3.2. By Treatment
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Lyme Disease Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Lyme Disease Treatment Market Dynamics
3.1. Market Drivers
3.1.1. Rising Incidence of Lyme Disease
3.1.2. Increasing Research Initiatives
3.1.3. Advancements in Diagnosis and Treatment
3.2. Market Challenges
3.2.1. Misdiagnosis and Lack of Awareness
3.2.2. High Cost of Treatment
3.3. Market Opportunities
3.3.1. Collaboration and Investment in Vaccine Development
3.3.2. Technological Advancements in Healthcare
Chapter 4. Global Lyme Disease Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Lyme Disease Treatment Market Size & Forecasts by Administration Route 2022-2032
5.1. Segment Dashboard
5.2. Global Lyme Disease Treatment Market: Administration Route Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Oral
5.2.2. Injectable
5.2.3. Topical
Chapter 6. Global Lyme Disease Treatment Market Size & Forecasts by Treatment 2022-2032
6.1. Segment Dashboard
6.2. Global Lyme Disease Treatment Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Medication
6.2.2. Tick Removal
Chapter 7. Global Lyme Disease Treatment Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Lyme Disease Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online
Chapter 8. Global Lyme Disease Treatment Market Size & Forecasts by Region 2022-2032
8.1. North America Lyme Disease Treatment Market
8.1.1. U.S. Lyme Disease Treatment Market
8.1.1.1. Administration Route breakdown size & forecasts, 2022-2032
8.1.1.2. Treatment breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Lyme Disease Treatment Market
8.1.2.1. Administration Route breakdown size & forecasts, 2022-2032
8.1.2.2. Treatment breakdown size & forecasts, 2022-2032
8.1.2.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.2. Europe Lyme Disease Treatment Market
8.2.1. U.K. Lyme Disease Treatment Market
8.2.2. Germany Lyme Disease Treatment Market
8.2.3. France Lyme Disease Treatment Market
8.2.4. Spain Lyme Disease Treatment Market
8.2.5. Italy Lyme Disease Treatment Market
8.2.6. Rest of Europe Lyme Disease Treatment Market
8.3. Asia-Pacific Lyme Disease Treatment Market
8.3.1. China Lyme Disease Treatment Market
8.3.2. India Lyme Disease Treatment Market
8.3.3. Japan Lyme Disease Treatment Market
8.3.4. Australia Lyme Disease Treatment Market
8.3.5. South Korea Lyme Disease Treatment Market
8.3.6. Rest of Asia-Pacific Lyme Disease Treatment Market
8.4. Latin America Lyme Disease Treatment Market
8.4.1. Brazil Lyme Disease Treatment Market
8.4.2. Mexico Lyme Disease Treatment Market
8.4.3. Rest of Latin America Lyme Disease Treatment Market
8.5. Middle East & Africa Lyme Disease Treatment Market
8.5.1. Saudi Arabia Lyme Disease Treatment Market
8.5.2. South Africa Lyme Disease Treatment Market
8.5.3. Rest of Middle East & Africa Lyme Disease Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GSK plc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Pfizer, Inc.
9.3.3. Novartis AG
9.3.4. Mayne Pharma Group Limited
9.3.5. Sun Pharmaceutical Industries Ltd.
9.3.6. Lupin Pharmaceuticals, Inc.
9.3.7. Orion Corporation
9.3.8. Perrigo Company plc.
9.3.9. Chartwell Pharma
9.3.10. Almirall, LLC
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes